<![CDATA[Abstract Pharmacy Oncology has made significant strides in improving cancer care through the development of targeted therapies, immunotherapies, pharmacogenomics, and nanotechnology. However, challenges remain in optimizing drug efficacy, managing adverse events, and ensuring equitable access to these advanced treatments. The evolving role of pharmacists in oncology will be crucial in addressing these challenges, ensuring that patients benefit from the latest advancements in cancer care. Pharmacy oncology plays a critical role in advancing cancer treatment by improving the efficacy, safety, and accessibility of therapies. This review highlights current trends in pharmacy oncology, including the emergence of targeted molecular therapies, immunotherapy innovations, nanoparticle-based drug delivery, and the integration of personalized medicine. Key challenges such as high treatment costs, drug resistance, and access disparities are explored alongside their implications for patient care. Future opportunities are identified, emphasizing advancements in pharmacogenomics, digital health technologies, and collaborative approaches to address unmet needs. This review underscores the necessity for continuous innovation to enhance therapeutic outcomes and improve the quality of life for cancer patients. Keywords: Oncology Pharmacy ; targeted therapies, immunotherapy, pharmacogenomics, Review]]>
Copyrights © 2025
